Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/13/2005WO2005095624A2 Filamentous fungal mutants with improved homologous recombination efficiency
10/13/2005WO2005095623A1 Method of introducing gene in target cell
10/13/2005WO2005095622A2 c-met siRNA ADENOVIRUS VECTORS INHIBIT CANCER CELL GROWTH, INVASION AND TUMORIGENICITY
10/13/2005WO2005095621A1 Method of regulating gene introduction with use of artificial magnetic material and system therefor
10/13/2005WO2005095620A2 Methods and compositions for regulating plant stress tolerance
10/13/2005WO2005095619A1 Plants with increased activity of multiple starch phosphorylating enzymes
10/13/2005WO2005095618A2 Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase
10/13/2005WO2005095617A2 Plants with increased activity of a starch phosphorylating enzyme
10/13/2005WO2005095616A1 A globulin-1-regulatory region and method of using same
10/13/2005WO2005095615A1 Assay for identifying compounds which affect stability of mrna
10/13/2005WO2005095614A1 Genes involved in plant fibre development
10/13/2005WO2005095613A1 Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095611A1 Method for the recombinant expression of an n-terminal fragment of hepatocyte growth factor
10/13/2005WO2005095610A1 Nucleic acid expressed in the hypothalamus or muscle tissue and uses thereof in diagnoses
10/13/2005WO2005095609A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
10/13/2005WO2005095608A1 Novel temperature regulated promoters and expression vectors from s.pombe
10/13/2005WO2005095607A2 ANTI-SENSE OLIGONUCLEOTIDES DIRECTED TOWARDS THE HIV ψ DOMAIN
10/13/2005WO2005095606A1 Therapeutic molecules for modulating stability of vegf transcripts
10/13/2005WO2005095605A1 Process for reducing the number of mismatches in double stranded polynucleotides
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095603A1 Detection instrument with the use of polynucleotides mapped on barley chromosome
10/13/2005WO2005095602A1 Novel modified s-hydroxynitrile lyase
10/13/2005WO2005095601A1 Method of evaluating drug-sensitivity by analyzing mu-opioid receptor gene
10/13/2005WO2005095600A1 Heparin-binding protein having heparan sulfate sugar chain attached thereto, process for producing the same and medicinal composition containing the same
10/13/2005WO2005095599A1 Novel fluorescent protein and gene encoding the same
10/13/2005WO2005095598A1 Cancer antigen peptide originating in wt1
10/13/2005WO2005095597A1 Method of breeding lipid-producing strain and utilization of the same
10/13/2005WO2005095591A2 Novel genes from a biosynthesis gene cluster for aminoglycoside antibiotic synthesis and the thus obtained novel aminoglycoside antibiotics
10/13/2005WO2005095588A1 Cortex glutamatergic neuron precursor providing cortex glutamatergic neuron and cortex glutamatergic neuron precursor alone in vivo
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005095461A2 Gold-binding protein and use thereof
10/13/2005WO2005095458A1 CHIMERIC MONOCLONAL ANTIBODY FOR BINDING WITH HIGH AFFINITY SELECTIVELY TO hCG
10/13/2005WO2005095457A2 Immunoglobulins
10/13/2005WO2005095456A1 An gene enginf; ering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
10/13/2005WO2005095452A1 Calcium ion leakage inhibitors
10/13/2005WO2005095451A1 Nucleotide and amino acid sequences for ruminant epidermal growth factor
10/13/2005WO2005095447A2 Low molecular weight forms of foxp1 proteins and splice variants thereof
10/13/2005WO2005095442A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
10/13/2005WO2005095117A2 Use of hydroxypropylated high amylose content potato starches to achieve high kit numbers
10/13/2005WO2005094900A1 Preventive and/or remedy for cancer
10/13/2005WO2005094899A1 Clusterin antisense therapy for treatment of cancer
10/13/2005WO2005094894A1 Preparation for transferring nucleic acid into cell
10/13/2005WO2005094890A1 Composition for increasing body height
10/13/2005WO2005094887A1 sFRP EXPRESSION POTENTIATING AGENT
10/13/2005WO2005094846A1 Remedy for prion disease and method of producing the same
10/13/2005WO2005094572A1 Nonhuman animal for constructing antibody and method and system of constructing antibody using the same
10/13/2005WO2005094571A1 Genetically modified hetero animal and method of measuring exocytosis using the animal
10/13/2005WO2005094570A1 Transgenic fish with increased unsaturated fatty acid content
10/13/2005WO2005094569A1 Ion channel
10/13/2005WO2005094562A1 Plants having improved growth characteristics and method for making the same
10/13/2005WO2005094533A2 Trail-r as a negative regulator of innate immune cell responses
10/13/2005WO2005094485A2 Drug screening
10/13/2005WO2005094453A2 Cospeptin, cosmedin and their uses
10/13/2005WO2005094415A2 Recombinant vectors and methods for inducing an immune response
10/13/2005WO2005094370A2 Oligonucleotide complex compositions and methods of use as gene alteration tools
10/13/2005WO2005094356A2 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
10/13/2005WO2005094355A2 Methods for altering protein production rates
10/13/2005WO2005094340A2 Method of reducing insect resistant pests in transgenic crops
10/13/2005WO2005094256A2 Polypeptides toxic to nematodes, and methods of use
10/13/2005WO2005080420A3 Hyphal growth in fungi
10/13/2005WO2005079170A3 Polypeptide participating in pyridoxine biosynthesis, a polynucleotide coding the polypeptide and those uses
10/13/2005WO2005073380A3 Regulated polymerase iii expression systems and related methods
10/13/2005WO2005058931A3 Methods and algorithms for identifying genomic regulatory sites
10/13/2005WO2005058479A3 Methods for synthesis of encoded libraries
10/13/2005WO2005058352A3 Treatment of rheumatoid arthritis with galectin-3 antagonists
10/13/2005WO2005056749A3 Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
10/13/2005WO2005051291A3 B-cell-targeted toxin for immuno response reduction
10/13/2005WO2005042784A3 Device and method for high-throughput quantification of mrna from whole blood
10/13/2005WO2005038035A3 Methods for producing and using in vivo pseudotyped retroviruses
10/13/2005WO2005035715A3 Flanking dna sequences that control expression in the human genome
10/13/2005WO2005035558A3 Piscirickettsia salmonis antigens and use thereof
10/13/2005WO2005031002A3 Synthetic lethal screen using rna interference
10/13/2005WO2005028658A9 Recombinant influenza vectors with a polii promoter and ribozymes
10/13/2005WO2005019474A3 Human autism susceptibility gene and uses thereof
10/13/2005WO2005005638A3 High affinity fusion proteins (rc-scfv-fc or scfv-scfv-fc) binding cytokines, particularly il-6 & il-18
10/13/2005WO2005003312A3 Elevation of oil levels in plants
10/13/2005WO2004090107A3 Endosomolytic polymers
10/13/2005WO2004081173A3 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
10/13/2005WO2004074509A3 Reversible attachment of a membrane active polymer to a polynucleotide
10/13/2005WO2004072253A3 Human excitatory amino acid transporter-2 gene promoter and uses thereof
10/13/2005WO2003099779A3 Hemipteran muscarinic receptor
10/13/2005WO2003088808A3 Compositions and methods for the diagnosis and treatment of tumor
10/13/2005WO2003078576A3 Vector for transfection of eukaryotic cells
10/13/2005WO2003078570A8 Multiple controls for molecular genetic analyses
10/13/2005WO2003069980A3 Precise breeding
10/13/2005WO2003068954A8 Microorganism for genetic therapeutic treatment of proliferative diseases
10/13/2005WO2002014467A9 Cng2b: a putative human cyclic nucleotide-gated ion channel
10/13/2005US20050229275 Production of biomedical peptides and proteins in plants using plant virus vectors
10/13/2005US20050229274 Regulated expression of cytokinin-Modulating genes
10/13/2005US20050229273 Enhancing the level of expression of a selected heterologous protein in seeds of transgenic plants
10/13/2005US20050229272 Compositions and methods for gene silencing
10/13/2005US20050229271 Compositions and methods for altering amino acid content of proteins
10/13/2005US20050229270 Using the polycomb proteins fertilization independent endosperm (FIE) and medea (MEA) for controlling activities of non-endosperm tissues such as floral meristem
10/13/2005US20050229269 Plant germplasm
10/13/2005US20050229268 Plant carbon catabolite repression proteins
10/13/2005US20050229267 Precise breeding
10/13/2005US20050229266 Method for producing non-human mammal RNAi phenotype using papilloma virus vector
10/13/2005US20050229265 Insect ammunition vectors and methods of use to identify pesticide targets
10/13/2005US20050229264 Recombinant gelatins
1 ... 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 ... 4023